Trial Profile
Retrospective study of bevacizumab in the treatment of cerebral radiation necrosis in patients with primary or metastatic brain tumors
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Necrosis; Radiation injuries
- Focus Therapeutic Use
- 25 Nov 2015 New trial record